… healthcare system in Italy will be considered, in this article, in the general perspective of public
health/clinical medicine … , for re-directing medicine and medical doctors toward a predictive…

… These qualities aid in developing targeted therapies, efficient novel drug candidates, early
diagnostic tools, and patient personalized medicines, which will be safer and more effective …

… In this review, we summarize recent advances in the discovery of new genes during the past
five years. Additionally, we summarize the latest guidelines by Amar et al. for the diagnosis …

… , efficient and powerful diagnostic and research discovery tool … , disease research, and
breeding. We conclude that several known disease alleles are more widespread across different …

… timely diagnosis and prompt treatment to prevent progression to end-stage renal disease. …
wide association studies might also inform precision medicine approaches. Here, we highlight …

… The HC group were participants who were systemically healthy without kidney diseases.
The other inclusion and exclusion criteria were the same as those for the ESRD group. All …

… was that LAVI and renal impairment have a synergic … new-onset AF was associated with
poor outcome and increased mortality in patients receiving LVAD. Basically, these latest insights …

… The effective application of gene therapies and recombinant protein products largely
depends on the development of individualized medicine, particularly in the area of cancer …

… spirit of personalized medicine that patients can uniquely or almost uniquely satisfy a medical
… For renal failure example at the beginning of this Section, 94% accuracy, 83% sensitivity, …

… This investigation focuses on kidney diseases that are most prevalent and therefore … this
work include developing new mechanism-based subtypes of kidney diseases that are common …